+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Contrast Media Market, by Product Type, by Application, by Modality, by Country, Industry Analysis and Forecast, 2019 - 2025

  • ID: 5006189
  • Report
  • February 2020
  • Region: Asia Pacific
  • 96 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Bayer AG
  • Bracco S.p.A.
  • Lantheus Holdings, Inc.
  • The Guerbet Group
  • MORE
The Asia Pacific Contrast Media Market is expected to witness market growth of 4.9% CAGR during the forecast period (2019-2025).

The Asia Pacific Contrast Media Market is growing at a fast pace. The ophthalmic laser market is expected to see remarkable growth in the forecast period due to an increase in the number of aging populations, increased research and development activities in the field of imaging modalities, demand image-guided techniques, and an increasing incidence of chronic diseases. Nonetheless, adverse reactions of contrast media on the body and the enormous costs involved hinder the market growth. Due to the huge population, China and India are likely to witness an increase in demand.

For MRIs, contrast agents minimize nuclei relaxation times within the tissues of the body to modify the contrast in an image. Gadolinium is a contrast agent used in MRI. The metal has seven unpaired electrons in the 3 + oxidation state, which helps water to relax quickly around the contrast agent, thereby improving the quality of the MRI scan. MRI contrast agents are commonly used to enhance the disparity in the contrast between normal and abnormal tissues. MRI contrast agents can be administered either orally or intravenously.

Based on Product Type, the market is segmented into Iodinated, Barium-based, Gadolinium-based and Microbubble. Based on Application, the market is segmented into Neurological disorders, Cancer, Cardiovascular disorders, Gastrointestinal disorders, Nephrological disorders, Musculoskeletal disorders and Other Applications. Based on Modality, the market is segmented into X-ray/CT, MRI and Ultrasound. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, General Electric (GE) Co. (GE Healthcare), The Guerbet Group, Lantheus Holdings, Inc., Bracco S.p.A., Trivitron Healthcare Pvt. Ltd., Nano Therapeutics Pvt. Ltd., Magnus Health, LLC (Veracross LLC), Imax Diagnostic Imaging Limited, and Daiichi Sankyo Company, Limited.

Scope of the Study

Market Segmentation:

By Product Type
  • Iodinated
  • Barium-based
  • Gadolinium-based
  • Microbubble
By Application
  • Neurological disorders
  • Cancer
  • Cardiovascular disorders
  • Gastrointestinal disorders
  • Nephrological disorders
  • Musculoskeletal disorders
  • Other Applications
By Modality
  • X-ray/CT
  • MRI
  • Ultrasound
By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
Companies Profiled
  • Bayer AG
  • General Electric (GE) Co. (GE Healthcare)
  • The Guerbet Group
  • Lantheus Holdings, Inc.
  • Bracco S.p.A.
  • Trivitron Healthcare Pvt. Ltd.
  • Nano Therapeutics Pvt. Ltd.
  • Magnus Health, LLC (Veracross LLC)
  • Imax Diagnostic Imaging Limited
  • Daiichi Sankyo Company, Limited
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Bayer AG
  • Bracco S.p.A.
  • Lantheus Holdings, Inc.
  • The Guerbet Group
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Contrast Media Market, by Product Type
1.4.2 Asia Pacific Contrast Media Market, by Application
1.4.3 Asia Pacific Contrast Media Market, by Modality
1.4.4 Asia Pacific Contrast Media Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : Sep, 2019-Mar, 2015) Leading Players

Chapter 4. Asia Pacific Contrast Media Market by Product Type
4.1 Asia Pacific Iodinated Market by Country
4.2 Asia Pacific Barium-based Market by Country
4.3 Asia Pacific Gadolinium-based Market by Country
4.4 Asia Pacific Microbubble Market by Country

Chapter 5. Asia Pacific Contrast Media Market by Application
5.1 Asia Pacific Neurological disorders Market by Country
5.2 Asia Pacific Cancer Market by Country
5.3 Asia Pacific Cardiovascular disorders Market by Country
5.4 Asia Pacific Gastrointestinal disorders Market by Country
5.5 Asia Pacific Nephrological disorders Market by Country
5.6 Asia Pacific Musculoskeletal disorders Market by Country
5.7 Asia Pacific Other Applications Market by Country

Chapter 6. Asia Pacific Contrast Media Market by Modality
6.1 Asia Pacific X-ray/CT Market by Country
6.2 Asia Pacific MRI Market by Country
6.3 Asia Pacific Ultrasound Market by Country

Chapter 7. Asia Pacific Contrast Media Market by Country
7.1 China Contrast Media Market
7.1.1 China Contrast Media Market by Product Type
7.1.2 China Contrast Media Market by Application
7.1.3 China Contrast Media Market by Modality
7.2 Japan Contrast Media Market
7.2.1 Japan Contrast Media Market by Product Type
7.2.2 Japan Contrast Media Market by Application
7.2.3 Japan Contrast Media Market by Modality
7.3 India Contrast Media Market
7.3.1 India Contrast Media Market by Product Type
7.3.2 India Contrast Media Market by Application
7.3.3 India Contrast Media Market by Modality
7.4 South Korea Contrast Media Market
7.4.1 South Korea Contrast Media Market by Product Type
7.4.2 South Korea Contrast Media Market by Application
7.4.3 South Korea Contrast Media Market by Modality
7.5 Singapore Contrast Media Market
7.5.1 Singapore Contrast Media Market by Product Type
7.5.2 Singapore Contrast Media Market by Application
7.5.3 Singapore Contrast Media Market by Modality
7.6 Malaysia Contrast Media Market
7.6.1 Malaysia Contrast Media Market by Product Type
7.6.2 Malaysia Contrast Media Market by Application
7.6.3 Malaysia Contrast Media Market by Modality
7.7 Rest of Asia Pacific Contrast Media Market
7.7.1 Rest of Asia Pacific Contrast Media Market by Product Type
7.7.2 Rest of Asia Pacific Contrast Media Market by Application
7.7.3 Rest of Asia Pacific Contrast Media Market by Modality

Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Approvals:
8.2 General Electric (GE) Co. (GE Healthcare)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 The Guerbet Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.3.5.3 Product Launches and Product Expansions:
8.4 Lantheus Holdings, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.5 Bracco S.p.A.
8.5.1 Company Overview
8.5.2 Regional Analysis
8.5.3 Recent strategies and developments:
8.5.3.1 Product Launches and Product Expansions:
8.5.3.2 Acquisition and Mergers:
8.5.3.3 Approvals:
8.6 Trivitron Healthcare Pvt. Ltd.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 Nano Therapeutics Pvt. Ltd.
8.7.1 Company Overview
8.8 Magnus Health, LLC (Veracross LLC)
8.8.1 Company Overview
8.9 Imax Diagnostic Imaging Limited
8.9.1 Company Overview
8.1 Daiichi Sankyo Company, Limited
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
Note: Product cover images may vary from those shown
3 of 3
  • Bayer AG
  • General Electric (GE) Co. (GE Healthcare)
  • The Guerbet Group
  • Lantheus Holdings, Inc.
  • Bracco S.p.A.
  • Trivitron Healthcare Pvt. Ltd.
  • Nano Therapeutics Pvt. Ltd.
  • Magnus Health, LLC (Veracross LLC)
  • Imax Diagnostic Imaging Limited
  • Daiichi Sankyo Company, Limited
Note: Product cover images may vary from those shown
Adroll
adroll